ICMT 抗体 (AA 182-231)
Quick Overview for ICMT 抗体 (AA 182-231) (ABIN6738283)
抗原
See all ICMT 抗体适用
宿主
克隆类型
标记
应用范围
-
-
抗原表位
- AA 182-231
-
特异性
- Human ICMT
-
预测反应
- Percent identity by BLAST analysis: Human, Mouse, Rat, Rabbit, Chicken (100%) Dog, Bovine, Horse, Pig, Xenopus (92%).
-
纯化方法
- Immunoaffinity purified
-
免疫原
-
Synthetic peptide located between aa182-231 of human ICMT (O60725, NP_036537). Percent identity by BLAST analysis: Human, Chimpanzee, Gorilla, Gibbon, Monkey, Galago, Marmoset, Mouse, Rat, Elephant, Rabbit, Guinea pig, Turkey, Zebra finch, Chicken (100%), Dog, Bovine, Bat, Horse, Pig, Opossum, Platypus, Xenopus (92%).
Type of Immunogen: Synthetic peptide -
亚型
- IgG
-
-
anti-Isoprenylcysteine Carboxyl Methyltransferase (ICMT) (AA 175-284) antibody
ICMT 适用: 人 WB, IHC 宿主: 兔 Polyclonal unconjugated
anti-Isoprenylcysteine Carboxyl Methyltransferase (ICMT) antibodyICMT 适用: 人, 小鼠, 大鼠 ELISA, IHC 宿主: 兔 Polyclonal unconjugated
anti-Isoprenylcysteine Carboxyl Methyltransferase (ICMT) (AA 86-154) antibodyICMT 适用: 人 WB, ELISA 宿主: 小鼠 Polyclonal unconjugated
anti-Isoprenylcysteine Carboxyl Methyltransferase (ICMT) (Middle Region) antibodyICMT 适用: 人, 小鼠, 大鼠 WB 宿主: 兔 Polyclonal unconjugated
anti-Isoprenylcysteine Carboxyl Methyltransferase (ICMT) (Middle Region) antibodyICMT 适用: 人, 小鼠, 大鼠, 豚鼠, 兔, Cow, 犬, 马, Saccharomyces cerevisiae WB 宿主: 兔 Polyclonal unconjugated
-
-
应用备注
-
Approved: WB
Usage: ELISA titer using peptide based assay: 1:1562500. Western Blot: Suggested dilution at 1 μg/mL in 5 % skim milk / PBS buffer, and HRP conjugated anti-Rabbit IgG should be diluted in 1:50000 - 100000 as second antibody. -
说明
-
Target Species of Antibody: Human
-
限制
- 仅限研究用
-
-
-
状态
- Lyophilized
-
溶解方式
- Distilled Water.
-
浓度
- Lot specific
-
缓冲液
- Lyophilized from PBS with 2 % sucrose
-
注意事项
- Avoid repeat freeze-thaw cycles.
-
储存条件
- 4 °C,-20 °C
-
储存方法
-
Long term: -20°C, the use of 50% glycerol is recommended if storing aliquots in -20°C for long term use (up to 1 year)
Short term (less than 1 week): 4°C. Avoid freeze-thaw cycles.
-
-
-
